We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+14.45%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$43.5B
AUM Growth
+$6.37B
(+17%)
Cap. Flow
+$123M
Cap. Flow
% of AUM
0.28%
Top 10 Holdings %
Top 10 Hldgs %
9.32%
Holding
3,484
New
550
Increased
1,237
Reduced
1,116
Closed
366
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$976M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$219M |
| 3 |
Humana
HUM
|
+$215M |
| 4 |
Pinterest
PINS
|
+$214M |
| 5 |
Snowflake
SNOW
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$301M |
| 2 |
Tesla
TSLA
|
+$254M |
| 3 |
Nike
NKE
|
+$248M |
| 4 |
Procter & Gamble
PG
|
+$233M |
| 5 |
Pfizer
PFE
|
+$232M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.09% |
| 2 | Financials | 10.23% |
| 3 | Consumer Discretionary | 10.17% |
| 4 | Healthcare | 10.17% |
| 5 | Industrials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Corvus Pharmaceuticals
CRVS
$1.17B
| $318K | ﹤0.01% |
180,704
-92,303
| -34% | -$135K |
|
2627
iShares US Small Cap Equity Factor ETF
SMLF
$4.27B
| $318K | ﹤0.01% |
+5,400
| New | +$284K |
|
|
STR
2628
DELISTED
Sitio Royalties
STR
| $316K | ﹤0.01% |
+13,458
| New | +$312K |
|
|
ACCD
2629
DELISTED
Accolade Inc
ACCD
| $316K | ﹤0.01% |
26,337
-24,400
| -48% | -$209K |
|
|
GATO
2630
DELISTED
Gatos Silver, Inc.
GATO
| $315K | ﹤0.01% |
48,190
-155,397
| -76% | -$863K |
|
2631
Epsilon Energy
EPSN
$173M
| $315K | ﹤0.01% |
62,023
-31,131
| -33% | -$166K |
|
2632
Asbury Automotive
ABG
$3.85B
| $315K | ﹤0.01% |
+1,400
| New | +$296K |
|
2633
Lincoln Educational Services
LINC
$1.3B
| $314K | ﹤0.01% |
31,246
+14,262
| +84% | +$130K |
|
2634
EVI Industries
EVI
$180M
| $314K | ﹤0.01% |
13,214
+2,158
| +20% | +$54.6K |
|
2635
Lexicon Pharmaceuticals
LXRX
$1.1B
| $310K | ﹤0.01% |
202,887
-442,481
| -69% | -$526K |
|
|
ENFN
2636
DELISTED
Enfusion, Inc.
ENFN
| $310K | ﹤0.01% |
31,989
-8,006
| -20% | -$74.8K |
|
|
KE
2637
Kimball Electronics
KE
$628M
| $310K | ﹤0.01% |
11,509
+2,824
| +33% | +$72.8K |
|
2638
Seneca Foods Class A
SENEA
$1.21B
| $309K | ﹤0.01% |
+5,897
| New | +$309K |
|
2639
Saic
SAIC
$5.35B
| $309K | ﹤0.01% |
+2,485
| New | +$289K |
|
2640
ACNB Corp
ACNB
$655M
| $309K | ﹤0.01% |
6,901
-2,098
| -23% | -$78.9K |
|
|
HARP
2641
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $307K | ﹤0.01% |
+27,042
| New | +$213K |
|
2642
Towne Bank
TOWN
$3.42B
| $307K | ﹤0.01% |
10,300
-112,938
| -92% | -$2.93M |
|
2643
Voya Financial
VOYA
$9.19B
| $306K | ﹤0.01% |
4,191
-76,180
| -95% | -$5.31M |
|
2644
Repligen
RGEN
$9.25B
| $306K | ﹤0.01% |
1,700
-11,377
| -87% | -$1.77M |
|
2645
Sana Biotechnology
SANA
$980M
| $305K | ﹤0.01% |
74,758
-47,768
| -39% | -$176K |
|
2646
Alto Ingredients
ALTO
$340M
| $304K | ﹤0.01% |
114,110
+5,300
| +5% | +$16.9K |
|
2647
SoundHound AI
SOUN
$3.49B
| $303K | ﹤0.01% |
+143,044
| New | +$283K |
|
2648
BancFirst
BANF
$3.8B
| $302K | ﹤0.01% |
3,100
-2,000
| -39% | -$175K |
|
2649
Compass Therapeutics
CMPX
$387M
| $301K | ﹤0.01% |
192,700
+167,000
| +650% | +$289K |
|
2650
Invesco S&P SmallCap 600 Pure Value ETF
RZV
$303M
| $300K | ﹤0.01% |
2,800
| – | – |
|
Similar funds
VAM
Two Sigma Investments's Q4 2023 Portfolio in Review
As of Q4 2023, Two Sigma Investments held 3,484 positions worth $43.5B, up 17% from $37.2B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Two Sigma Investments's Q4 2023 filing shows 550 new, 1,237 increased, 1,116 reduced and 366 closed positions. Its largest new stake was Becton Dickinson: 732,254 shares worth $179M. The largest sale was Palantir, an estimated $301M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
- Two Sigma Investments's largest Q4 2023 buy was Becton Dickinson: 732,254 shares worth $179M.
- Two Sigma Investments added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $976M increase.
- Two Sigma Investments's biggest Q4 2023 reduction was Palantir, cutting an estimated $301M.
- Two Sigma Investments fully exited Tesla in Q4 2023, selling an estimated $254M.
- Two Sigma Investments's ten largest holdings make up 9.3% of its $43.5B portfolio in Q4 2023.
- Two Sigma Investments opened 550 new positions and closed 366 in Q4 2023.
- Two Sigma Investments's portfolio value rose 17% quarter-over-quarter to $43.5B.
Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.